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Abstract
Background: Type B GABA receptors (GABA Rs) play a critical role in synaptic transmission. We carried out studies
to determine whether neuronal cell surface expression of GABAB-Rs might be regulated by the Nogo receptor
1 (NgR1).
Results: siRNA knock-down of NgR1 resulted in a selective increase of GABAB R1 and GABAB R2 protein without
altering the expression of GABAA receptor or GAD65. The increase in GABAB receptor subunits was unaccompanied
by a change in mRNA, but inhibition of mTOR by rapamycin blocked the increase in GABAB protein. NgR1 siRNA
also caused an increase in G protein coupled inwardly rectifying potassium channel (GIRK1). The increase in GABAB
receptor and GIRK1 channel proteins was in the plasma membrane, determined by cell surface biotinylation. In
NgR1 knockout mice, the amount of GABAB R2 and GIRK1 in hippocampus-derived synaptosomes was increased.
Conclusions: Together these findings suggest that NgR1 mediated modulation of synaptic transmission may be
accomplished, at least in part, through modulation of G protein coupled receptors and channels.
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Background
The balance between plasticity and stability of synaptic
connections in neuronal networks is maintained by a
dynamic process of biochemical and structural modifi-
cations. Synaptic changes are prominent during devel-
opment, but the process persists in more subtle forms
throughout the lifespan and can be observed in re-
sponse to learning, as a result of injury and in aging
[1-3]. A number of glial inhibitors of axonal regener-
ation originally identified in injury models, are also
found in neurons of the uninjured CNS and localized
to synaptic sites where they function to restrict synap-
tic plasticity. In particular, NgR1 and its ligand NogoA
have been implicated in activity dependent refinement
of neuronal synapses in the CNS; in the visual cortex,
NgR1 and NogoA are important for the consolidation
of synaptic connections established during the critical
period [4].
In the hippocampus NgR1 restricts formation of ex-
citatory synapses [5], limits activity dependent synap-
tic strength and regulates dendrite spine morphology
[6], while dynamic regulation of NgR1 in the forebrain
is required for consolidation of long lasting memory
[7]. Similarly, NogoA restricts synaptic plasticity in
the adult hippocampus where NogoA neutralization,
shRNA knockdown or deletion of NogoA induced
changes in dendritic structure of pyramidal neurons
and resulted in increases in long term potentiation
[8,9]. These electrical and structural changes correlate
with an increase in NMDA and AMPA receptor sub-
units and the scaffolding protein PSD95 that we previ-
ously found to occur in hippocampal neurons dendritic
spines by mammalian target of rapamycin (mTOR)
mediated activation following deletion of NogoA or
NgR1 [10].
Less is known about the role of NogoA or NgR1 in
non-glutamatergic synaptic connections. In transgenic
mice, overexpression of NogoA causes progressive loss
of inhibitory Purkinje cell terminals in deep cerebellar
nuclei and deficits in motor coordination [11], a loss that
is attributed to decreased expression of synaptic scaf-
folding proteins. Here we report a novel function for
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NgR1 in hippocampal neurons. We found that knock
down of NgR1 enhances levels of GABAB receptors and
the downstream GIRK channel in the plasma membrane
by a post-transcriptional mechanism that engages the
rapamycin sensitive mTOR pathway. The effect appears
to be selective, as NgR1 did not affect expression levels
of the GABAA receptor or glutamic acid decarboxylase
65 (GAD65).
Results
Post-transcriptional regulation of GABAB receptor by
NgR1
The NogoA-NgR1 interaction limits synaptic plasticity
in part by restricting glutamate receptor expression. In
order to know if NgR1 signaling may also influence sur-
face expression of GABA receptors, we used primary
postnatal hippocampal neurons (DIV14-17) treated with
siRNA specific for NgR1 to determine levels of GAD65,
responsible for GABA synthesis, and the GABA recep-
tors GABAA and GABAB. Western blot analysis re-
vealed that knock-down of NgR1 causes a significant
increase in GABAB receptor subunits R1 and R2 protein
compared to control siRNA (csiRNA) treated cultures
(Figure 1A). Knock-down of NgR1 had no effect on ex-
pression levels of GABAA or GAD65 protein (Figure 1B).
The knock-down of NgR1 by siRNA was confirmed by
Western blot analysis (Figure 1C). mRNA levels mea-
sured by quantitative PCR analysis at the same time
point did not change in NgR1 siRNA-treated hippo-
campal cultures compared to csiRNA-treated cultures
(GABAB R1: csiRNA 1.01 ± 0.10 and NgR1siRNA 1.14 ±
0.11; GABAB R2: csiRNA 1.00 ± 0.03 and NgR1siRNA
1.01 ± 0.11). This indicates that the increase in GABAB
R1 and GABAB R2 proteins represents a post-
transcriptional process.
We have previously shown that siRNA knock-down
of NogoA or NgR1 in hippocampal neurons increases
mTOR phosphorylation and increases levels of gluta-
matergic receptors in dendritic spines; an effect that
can be prevented by blocking mTOR signaling [10]. In
order to determine whether mTOR activation caused
by NgR1 knock down plays a similar role in the up-
regulation of GABAB R1 and R2 subunit expression,
we treated hippocampal neurons with rapamycin, an
inhibitor of mTOR. Rapamycin blocked in part the in-
crease in GABAB receptor subunits caused by NgR1
siRNA (Figure 1D) suggesting that GABAB receptor
subunit expression may be under translational control
downstream of mTOR. Rapamycin treatment of control
hippocampal cultures produced no significant change
in GABAB R1 or GABAB R2 protein levels (Additional
file 1: Figure S1).
GABAB receptors are G-protein coupled receptors
(GPCRs) localized to the presynaptic and postsynaptic
domains of excitatory and inhibitory neurons and me-
diate heterogeneous GABA responses. In the hippo-
campal cultures used in these experiments GABAB R1
and GABAB R2 were present in almost all the neurons,
appearing as punctae on MAP2 positive dendrites
(Figure 2A). The in vitro preparation consisted pre-
dominantly of glutamatergic neurons (75-80% as deter-
mined by vGlut1 staining) with the remainder (20-25%)
characterized as GABAergic by vesicular GABA trans-
porter (vGAT) immunostaining (Figure 2B). There was
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Figure 1 Enhanced expression of GABAB receptor subunits by
NgR1 siRNA is prevented by rapamycin. Hippocampal neurons
(DIV 14–17) treated with csiRNA or NgR1 siRNA. A. NgR1 siRNA
significantly increased GABAB R1 and GABAB R2 protein levels.
B. GABAA and GAD65 levels were unchanged. C. Knock down of
NgR1 expression by NgR1 siRNA but not by csiRNA or NogoA siRNA
used as controls. D. Rapamycin (100 nM) prevented the increased
expression of GABAB R1 and GABAB R2 caused by NgR1 siRNA. Each
sample was calculated as a ratio to β-actin and presented as
percentage of control. * P < 0.05 and ** P < 0.01.
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an extensive array of vGAT positive terminals on den-
drites and soma of non-GABAergic neurons in these
cultures (Figure 2C).
NgR1 restricts GIRK1 levels
G-protein coupled GABAB receptors influence second
messenger systems and ion channels including the G-
protein gated inwardly rectifying potassium channels
(GIRKs) and voltage-dependent calcium channels,
which together determine the slow and complex nature
of the GABA response. GIRKs are tetrameric com-
plexes of several channel subunits (GIRK1-4) and in
the brain GIRK 1 associates primarily with GIRK2 and
GIRK3. We chose to study GIRK1 because of its direct
interaction with the GABAB R1 subunit and the special
role it plays in determining channel activity [12,13]. We
found that knock-down of NgR1 by siRNA in hippo-
campal neurons causes an increase in GIRK1 protein
when compared to treatment with csiRNA (Figure 3A).
GIRK1 immunostaining is seen in all hippocampal
neuron cell bodies and along an extensive neurite
network as shown in association with GABAB R1
(Figure 3B and C).
The increase in GABAB subunits and GIRK occurs at the
plasma membrane
In order to assess if the changes we observed in GABAB
receptor subunits and GIRK1 caused by NgR1 siRNA re-
flect the levels of those proteins in the plasma mem-
brane, we performed surface protein biotinylation of
hippocampal neurons in culture treated with either
NgR1 siRNA or csiRNA. After cell lysis, normalization
and pull down of biotinylated proteins, equal amounts
of sample were assayed from each experimental condi-
tion. Western blot analysis shows an increase in surface
GABAB R1, GABAB R2 and GIRK1 in cultures treated
with NgR1 siRNA as compared to csiRNA treated cells
(Figure 4A). No contamination with cytosolic protein
was observed as GAPDH was not seen by Western blot
in these samples.
GABAB and GIRK1 are increased in synaptosomes of NgR1
knockout mice
To examine whether the changes induced by NgR1
siRNA in primary hippocampal neurons in vitro also
occur in vivo, we isolated synaptic density fractions from
hippocampal tissue of adult wildtype and NgR1 knockout
mice [6]. Analysis of protein levels in synaptosomal
MAP2/GABABR1
MAP2/GABABR2
VGAT/MAP2
VGlut1/MAP2
VGAT/MAP2
A B
C
Figure 2 GABAB R1 and GABAB R2 are localized on dendrites in the cultured neurons. A. GABAB R1 (green) and GABAB R2 (green)
localized in a punctate distribution along dendrites stained with MAP2 (red) in postnatal hippocampal neurons; scale bar = 25 μm. Inserts show
higher magnification of the outlined area. B. Approximately 20% of the hippocampal neurons were GABAergic (arrows), stained with vGAT
(red) and MAP2 (green), while the majority (80%) were glutamatergic stained with vGlut1 (red) and MAP2 (green) and shown in the insert. Scale
bar = 25 μm. C. An extensive array of vGAT processes and terminals (red) contacting other non-GABA neurons (MAP2 green); scale bar = 10 μm.
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preparations from hippocampus of adult brains showed
similar changes to those seen in hippocampal neurons
in vitro. GABAB R2 and GIRK1 proteins were signifi-
cantly increased in the synaptosomes from NgR1 knock
out as compared to control mice (Figure 4B), suggesting
that the upregulation is occurring at synapses in vivo.
While the GABAB R1 level also increased, this did not
reach statistical significance when compared to control
(Figure 4C).
Discussion
We explored the role of NgR1 in modulating expression
of GABA receptors in hippocampal neurons using
siRNA knock-down and NgR1 knockout mice. We found
that NgR1 modulates levels of GABAB receptors and
GIRK channel at the plasma membrane and in synapto-
somes. The changes we found appear to be specific as
NgR1 knock down does not modify the GABAA recep-
tor or GAD65 protein levels. The regulation of GABAB
expression by NgR1 is post-transcriptional and mediated
by the rapamycin sensitive mTOR pathway, similar to
the mechanism that we previously reported in the regu-
lation of glutamate receptor expression by NogoA-NgR1
signaling, and that has been implicated in the develop-
ment of LTP and dendritic spine morphology [8-10,14].
GABAB receptors are heterodimers composed of
GABAB R1 and GABAB R2 subunits and in the hippo-
campus both subunits are present in dendrites where
they localize to the extra-synaptic membrane of spines
and dendritic shafts where they mediate the slow inhibi-
tory postsynaptic currents [15,16]. Heterodimerization
of the receptor is a requisite for stable surface expression
of GABAB receptors [17] and the density of membrane-
Figure 3 Down-regulation of NgR1 increases GIRK channels.
A. Treatment of hippocampal neurons with NgR1 siRNA increases
the level of GIRK1. Each sample was calculated as ratio to β-actin
and presented as percentage of control. * P < 0.05. B. GIRK1 protein
(red) is expressed in all neurons; scale bar = 10 μm. C. GIRK1 in
dendrites (red) co-localized with GABAB R1 (green); scale bar = 2 μm.
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Figure 4 Changes in GABAB and GIRK by down-regulation of
NgR1 in plasma membrane and synaptosomes. A. In vitro
biotinylation of hippocampal neurons in culture shows increased
GABAB R1, GABAB R2 and GIRK1 in the membrane fraction in cells
treated with NgR1 siRNA. B. Increased GABAB R2, GIRK1 and to a
lesser extent GABAB R1 were found in a synaptosomal preparation
from hippocampal region from NgR1 knockout mice. C. Quantitative
analysis of results presented in B. Each sample was calculated as a
ratio to β-actin and is presented as percentage of control. * P < 0.05.
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localized receptors is one factor in determining signaling
strength in response to changing physiological condi-
tions. In our cultured hippocampal neurons GABAB R1
and R2 appeared as puncta on dendrites and cell bodies
of glutamatergic and GABAergic neurons, and NgR1
knockdown significantly increased the amount of the
GABAB receptor subunits in the plasma membrane
without altering mRNA levels. These results suggest that
conditions altering NgR1 activation may have effects on
GABA mediated signaling.
GABAB receptors traffic through the ER and Golgi
networks for delivery to the plasma membrane and once
at the cell surface undergo constitutive endocytosis and
are rapidly recycled to the cell surface [18,19]. However
in hippocampal neurons GABAB R1 and R2 subunits
may also heterodimerize and assemble to form func-
tional receptors at the plasma membrane, a process that
is highly dynamic and regulated by intra- and extra-
cellular cues [20]. Our studies indicate that rapamycin-
sensitive mTOR signaling mediates the up-regulation of
GABAB receptor expression, thus providing a post-
transcriptional mechanism by which the neuron may
exert local control of GABAB receptor expression in re-
sponse to changing NgR1 levels.
While GABAB R1 contains the ligand binding do-
main, GABAB R2 associates with pertussis toxin sensi-
tive G family of proteins (Gαi/o). Activation of the
receptor triggers GTP-dependent release of G-protein
heterodimers which regulate second messengers and
ion channels. Oligomerization of GABAB receptors
and GIRK channels produces stable macromolecular
complexes that localize to the plasma membrane [21]
where GIRK1 appears to interact in a direct and spe-
cific manner with GABAB R1 [12]. Our results are
consistent with a physical or functional interaction of
GABAB and GIRK1, as levels in the cell membrane
and in synaptosomes appeared jointly regulated by
NgR1. Our work does not address the functional out-
come of GABAB and GIRK regulation by NgR1, but
GABAB and GIRK complexes are known to generate
slow inhibitory post-synaptic responses and to reduce
network activity [22,23].
Conclusions
We found that GIRK1 levels are regulated together with
GABAB receptor subunits B1 and B2 in the plasma
membrane and in synaptosomes, suggesting that NgR1
signaling may contribute to synaptic modifications by
restricting GABAB-GIRK complex mediated effects in
the hippocampus. Taken together, these data suggest
that NogoA-NgR1 signaling may play a modulatory role
in the complex regulation of neuronal excitability and/or
synaptic network activity.
Methods
Tissue culture
Hippocampal neurons were isolated from postnatal day
2 (P2) Sprague Dawley rats (Charles River, Portage, MI,
USA) and were cultured in defined Neurobasal medium
(Invitrogen, Carlsbad, CA, USA) as previously described
[10]. The studies were approved by the VA Ann Arbor
Healthcare System Animal Studies Committee, and ap-
propriate measures were taken to minimize pain and
discomfort. Tissue culture studies were performed at
DIV14-17 when the neurons display a mature pheno-
type. Rapamycin (Tocris Bioscience, Bristol, UK) was
added to the culture medium for 24 hours as indicated.
siRNA preparation and transfection
ON-TARGET plus SMARTpool siRNA directed against
NgR1 and ON-TARGET plus siCONTROL non-
targeting pool siRNA were used (Dharmacon, Chicago,
IL, USA). The siRNA sequences were as we described
previously [10]. Transfection solution contained 2.5 μl of
siRNA in 47.5 μl of antibiotic free culture medium and 2
μl of DharmaFECT siRNA transfection reagent 3
(Dharmacon) in 48 μl of cultured medium. The mixture
was incubated for 20 min at 21°C. Hippocampal neurons
(DIV14) were treated with the transfection solution for
72 h, at which point cell homogenates were collected for
RNA and protein analysis.
RNA isolation and quantitative PCR
Total RNA was isolated using the RNeasy Mini kit
(Qiagen, Valencia, CA, USA) from hippocampal neurons
transfected with either NgR1siRNA and csiRNA as de-
scribed above. RNA quality was monitored by agarose
electrophoresis. Reverse transcription was conducted
using the Superscript Reverse Transcriptase II kit
(Invitrogen) and the cDNA obtained used for quantita-
tive PCR (qPCR) determination. Primers were mixed
with iQ5 SybrGreen Supermix (BioRad Laboratories,
Hercules, CA, USA) and amplification was carried out
in 25 μl of iQ5 Real-Time PCR detection system using a
two-step qPCR protocol with the initial denaturing step
at 95°C for 3 minutes followed by 40 cycles (95°C for 20
seconds, 58°C for 30 seconds). The primers used for
qPCR are as follows. For GABAB R1 amplification, the
forward primer is 5′-ACAAGGGGCTGCTGCTGCTG
−3′ and the reverse prime is 5′-GATAGCCATGC
CCACGGCCC −3′. For GABAB R2 amplification, the for-
ward primer is 5′-AAACGTTCAGGCGTGGGGCC-3′
and the reverse primer is 5′-CCGCTGGTGCCTGC
TACTGG-3′. For β-actin amplification, the forward
primer is 5′-CAGTTCGCCATGGATGACGATATC-3′,
and the reverse primer is 5′-CACGCTCGGTCA
GGATCTTCATG-3′. Levels of mRNA for GABAB R1
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and R2 were calculated in relation to levels of β-Actin
mRNA (internal control) using the 2−ΔΔCt method [24].
Western blot
Primary hippocampal neurons were collected in lysis
buffer (50 mM Tris, 10 mM NaCl, 1% Nonidet P-40,
0.02% NaN3) containing 1% protease and phosphatase
inhibitor cocktail (Sigma, St Louis, MO, USA) and
Western blot performed and analyzed as described [10].
Primary antibodies were: anti-NgR1 (1:100, R&D Sys-
tems, Minneapolis, MN, USA), anti-GABAB R1 (1:200,
Santa Cruz Biotechnology, Santa Cruz, CA, USA); anti-
GABAB R2 (1:400, NeuroMab, UC Davis/NIH, CA,
USA) anti-GIRK1 (1:200, Sigma), anti-GABAA α1 sub-
unit (Millipore, Billerica, MA, USA), anti-GAD65
(1:1000, Chemicon, Temecula, CA, USA) and anti β-
actin (1:4000, Sigma). Secondary antibodies were perox-
idase coupled (1:2000, Santa Cruz Biotechnology or
1:3000, Jackson ImmunoResearch, West Grove, PA) and
amplified using SuperSignal chemoluminescence re-
agent (Pierce). Chemiluminescence of each protein
band was quantitated using a ChemiDoc (Bio-Rad) de-
vice. The quantitative analysis was performed as follows.
The chemiluminescent intensity of the band repre-
senting the protein of interest (with the background
subtracted) was compared to the chemiluminescent in-
tensity of the corresponding internal control β-actin
(background subtracted) for each sample in the experi-
mental group, and then the results were compared to
the control samples from the same blot quantitated in a
similar manner with the control set as 1, so as to deter-
mine the percentage change between the experimental
treatment and the control treatment for each sample
group. The results presented represent a summary of at
least 3 independent experiments.
Cell surface biotinylation
Following siRNA transfection, hippocampal neurons
underwent cell surface biotinylation using the Pierce Cell
Surface Protein Isolation kit (Thermo Scientific, Rockford,
IL, USA). Cells were labeled with the non-cell membrane
permeabilizing reagent EZ-Link Sulfo-NHS-Biotin for
30 min at 4°C and the labeling reaction was stopped by
adding the Quenching solution according to the kit in-
structions. At the completion of the reaction cells were
washed and lysed in the presence of protease inhibitors
at 4°C. Cell lysates were centrifuged at 10,000 × g for
2 minutes and the supernatants collected were normal-
ized to have similar amounts of total protein. The
biotinylated proteins from each sample were isolated
using NeutrAvidin Agarose. The bound proteins were
washed and released by incubating in SDS-PAGE sam-
ple buffer containing 50 mM DTT. Equal amounts of
treated and control samples were used for SDS-PAGE
and Western blot analysis. Anti-GAPDH (Santa Cruz
Biotechnology) representing the cytosolic compartment,
was used as control for the purity of the sample and
detected no protein band.
Immunocytochemistry
Hippocampal neurons were fixed, blocked and probed
overnight with the following antibodies anti-GABAB
R1 (1:200, Santa Cruz Biotechnology); GABAB R2
(1:400, NeuroMab) anti-GIRK1 (Sigma), anti-MAP2
(1:1000, Millipore, Billerica, MA, USA), anti-vGlut1
(1:1000, Chemicon International) and anti-vGAT (1:1000,
Millipore). The secondary antibodies were tagged to
Alexa Fluor 594 or 488 (1:2000, Invitrogen). Images
were acquired using a Nikon E1000 fluorescent micro-
scope with a Photometric Cool Snap ES camera and
Metamorph software.
Preparation of synaptosomes
Synaptosomes were obtained from 7–8 week old male
wild type (NgR1+/+) and NgR1 (NgR1−/−) knockout mice
(C57Bl/6 background) that were generously provided by
Marc Tessier-Lavigne (Rockefeller University, NYC, NY)
[25]. The isolation of synaptosomes was performed as de-
scribed previously [14]. Briefly, each preparation was gen-
erated from hippocampi of four NgR1knockout mice or
four wild-type mice and the tissues were homogenized in
a 0.32M sucrose solution containing 0.1 mM CaCl2, 1
mM MgCl2, 0.1 mM PMSF, 25 mM NaF, and 1 mM
Na3VO4. The sucrose concentration was adjusted to
1.25M, using a 2M sucrose solution containing 0.1 mM
CaCl2, and synaptosomes were collected from the 1.25M/
1M interface of a prepared sucrose gradient by centrifuga-
tion at 100,000 × g for 3 hr at 4C in a Sorvall Ultracentri-
fuge using a SW41 rotor. Isolated synaptosomes were
adjusted to the same final protein concentration and ana-
lyzed by SDS-PAGE. Three synaptosomal preparations
were obtained from NgR1 knock-out mice and three simi-
lar samples were obtained from control mice.
Data analysis
Data are shown as mean ± SE. The statistical significance
of the difference between treated and control group was
determined by one way ANOVA using SPSS 12.0 for
Windows (SPSS Inc. Amonk, NY, USA) with p < 0.05
considered significant. All experiments were performed
at least three times using independent samples.
Additional file
Additional file 1: Figure S1. Treatment of hippocampal neurons with
100 nM repamycin for 24 h did not change baseline levels of GABAB R1,
GABA R2, GABAA or GIRK1 protein, calculated as a ratio to the
corresponding β-actin internal control.
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